09 Jun 2017

Five questions with ICG Enterprise Trust's Emma Osborne

Secondaries Investor - June 2017

In February last year, Intermediate Capital Group acquired the London-listed fund investment business of Graphite Capital.

Secondaries Investor caught up with Emma Osborne, the vehicle's head of private equity fund investments, about what has changed in the 16 months since the acquisition and her plans for the Trust over the next five years.

How has being part of ICG affected your investments over the last 16 months?

It has been incredibly helpful in giving us access to a broader range of dealflow and insights into the market. At Graphite, we always felt that being an LP within a GP was a competitive advantage, and we’ve retained that dynamic. However, Graphite did around 10-12 deals over a five-year investment period in a quite narrow part of the UK mid-market, whereas at ICG we’ve got access to 136 investment professionals in 13 countries, most of whom are doing deals with private equity managers every day. It’s hugely valuable for us to be able to pick up the phone and get insights into managers we’re looking at backing from colleagues with first-hand experience.

How has your investment focus changed?

Fundamentally we’re doing the same but with a slight shift in emphasis. One of the objectives was to increase US exposure.  At Graphite we were almost entirely Europe focused but when you look at performance, the US has outperformed Europe every vintage since 2005 for buyout. Many of our peers have benefited from that and from
currency gains when converting that back into sterling. We had felt we were too far out of line with our peers and wanted to be more balanced. We started looking more at the US while we were still at Graphite, but now we can accelerate that with a lot more confidence. We’ve gone from 14 percent to 21 percent [US exposure] in the year and I expect that trend will continue. We have a medium-term aim of 30 to 40 percent in the US.

We are also doing more with in-house strategies which, as well as offering a good balance of risk and return, gives our shareholders a fee advantage as we don’t charge a fee on those. We’ve been long-term backers of the European mezzanine and equity strategy and we’ve also added the ICG Strategic Secondaries fund, which focuses on end-of-life fund restructurings, and the Asia-Pacific mezzanine fund.

What types of deals are you looking at?

We are looking to do more “high-conviction” investments which include ICG directly managed investments, co-investments and secondaries. These are investments that we have a high conviction will outperform and where we have done the due diligence on the underlying company. Blind-pool investments go in the portfolio on average at around £1 million of exposure whereas when we make a co-investment we’re looking to add £10 million or more, so we are massively increasing our exposure to these assets. For these deals we are looking for highly defensive businesses with market-leading positions and strong management teams we think will be able to weather economic cycles.

At the moment, the high-conviction portion is 42 percent, but our medium-term target is 50 to 60 percent. Last year we also did a number of late primaries where there were assets in the fund when we committed. Out of 10 new fund commitments, four had this feature. This means there was almost 60 percent of new investment where we’d been able to do due diligence on the underlying company before it was added to the portfolio, which is different from a pure fund of funds investor.

How would the Trust be different today if you had not joined ICG?

There were three big challenges the board set us when we moved. One was to get more fully invested; one was to increase proportion of the portfolio that’s in ICG investments, and the third was to increase US investments.

We’ve historically been underinvested and in the last five years the cash drag has cost us an average of 2.2 percent a year in performance. We arrived at ICG with 20 percent cash and we ended the year 94 percent invested and I’ve got no doubt that being part of ICG has helped us get there. Also, some of the third-party opportunities came through the ICG network, so I think we would have invested in a different opportunity set.

What is your vision for the Trust over the next five years

I would like to think that we will be part of a thriving listed private equity sector, as I think it’s a brilliant product for retail investors and small institutions.

We’d like to increase both the co-investments and secondaries from the 25 percent and 15 percent today. We’ve added one to the team and we will almost certainly be hiring [another]. We’ve got strong co-investment experience on the team but it’s possible that we’ll add somebody from a traditional secondaries background. We’ve done 24 LP secondaries deals since 2010 and invested around $200 million but we’d like to beef that up. We’re having those conversations in conjunction with Andrew [Hawkins, ICG’s head of secondaries] and his team over how we can best work together.

Emma Osborne is ICG Enterprise Trust’s head of private equity fund investments. She has more than 22 years of experience in private equity and has been the lead portfolio manager for at the Trust for almost 13 years. Osborne previously spent 10 years in various roles in private equity, including at Merrill Lynch Investment Managers, Morgan Grenfell Private Equity, Royal Bank of Scotland and Coopers & Lybrand.

Share price (ICGT)

34.00P (3.23%)
3:17AM 17 May 2022
The share price information is delayed by at least 15 minutes

Net Asset Value

As of 31 January 2022
Full year results for the twelve months ended 31 January 2022
Year Net assets NAV per share Share price Dividends per share
Jan 2021 £952m 1,384p 966p 24p
Jan 2020 £794m 1,152p 966p 23p
Jan 2019 £731m 1,057p 822p 22p
Jan 2018 £664m 959p 818p 21p
Jan 2017 £613m 871p 698p 20p
Jan 2016 £521m 731p 545p 11p
Jan 2015 £507m 695p 575p 15.5p
Jan 2014 £494m 677p 563p 15.5p
Jan 2013 £460m 631p 487p 5p
Jan 2012 £415m 569p 357p 5p
Jan 2011 £389m 534p 308p 2.25p
Dec 2009 £338m 464p 305p 2.25p
Dec 2008 £327m 449p 187p 4.5p


The information contained herein and on the pages that follow does not constitute an offer to sell, or the solicitation of an offer to acquire or subscribe for, any securities in any jurisdiction where such an offer or solicitation is unlawful or would impose any unfulfilled registration, qualification, publication or approval requirements on ICG Enterprise Trust PLC (the "Company") or its affiliates or agents. Equity securities in the Company have not been and will not be registered under the applicable securities laws of the United States, Australia, Canada, Japan or South Africa (each an “Excluded Jurisdiction”). The equity securities in the Company referred to herein and on the pages that follow may not be offered or sold within an Excluded Jurisdiction, or to any U.S. person ("U.S. Person") as defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or to any national, resident or citizen of an Excluded Jurisdiction.

The promotion of the Company and the distribution of this website and the materials contained by it in the United Kingdom are restricted by law. Accordingly, this website and any materials contained by it should only be accessed by, and are directed only at:
(i) persons outside the United Kingdom to whom it is lawful to communicate to; or
(ii) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”); or
(iii) high net worth companies, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Order, provided that in each case the website and any materials in are only directed at persons who are "qualified investors" as defined in article 2(1)(e) of Directive 2003/71/EC (as amended) (the "Prospectus Directive") ("Relevant Persons"). Accordingly, this website does not constitute, and does not contain the information required to be contained in, a prospectus as required under the Prospectus Directive.

This website is communicated by ICG Alternative Investment Limited (“ICG AIL”), which is authorised and regulated by the UK Financial Conduct Authority. In communicating this website ICG AIL is acting for the Company and is not responsible for advising persons viewing this website or any other person, or for providing them with the protections which would be given to those who are clients of ICG AIL under the rules of the FCA.
The information on the pages that follow may contain forward looking statements. Any statement other than a statement of historical fact is a forward looking statement. Actual results may differ materially from those expressed or implied by any forward looking statement. The Company does not undertake any obligation to update or revise any forward looking statements. You should not place undue reliance on any forward looking statement, which speaks only as of the date of its issuance.

Your access to this website is governed by the above terms. The Company may change these terms. The changes will be posted on the website. Your access to this website is governed by the version of these terms then in force.

By clicking "I understand and agree" below, you represent, warrant and agree that you (1) have read and understood these terms and the other information set out above, (2) agree to be bound by the terms, (3) do not have a registered address in, and are not resident or located in, an Excluded Jurisdiction (or, if you do, you will not seek to make any investment in the securities of the Company), (4) are not a U.S. Person or a national, resident or citizen of an Excluded Jurisdiction (or, if you are, you will not seek to make any investment in the securities of the Company), (5) are permitted under applicable laws and regulations to receive the information contained in the pages that follow, and (6) agree that you will not transmit or otherwise send any information contained in this website to any person in the United States or to any U.S. Person for the purpose of that person considering an investment in the securities of the Company, or to any publication with a general circulation in the United States.
If you cannot so certify and agree, you must click the button labelled "I decline" or otherwise exit this website.